A carregar...
The Promise of Chimeric Antigen Receptor (CAR) T Cell Therapy in Multiple Myeloma
A cure for multiple myeloma (MM), a malignancy of plasma cells, remains elusive. Nearly all myeloma patients will eventually relapse and develop resistance to currently available treatments. There is an unmet medical need to develop novel and effective therapies that can induce sustained responses....
Na minha lista:
| Publicado no: | Cell Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6832886/ https://ncbi.nlm.nih.gov/pubmed/31492448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2019.103964 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|